PEG-interferon versus conventional interferon and liver fibrosis: do we have evidence of superiority?
Sander
Guilherme
G
Picon
Paulo D
PD
Fuchs
Flávio D
FD
Beltrame
Alberto
A
De Souza
Renilson R
RR
D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D007372:Interferons; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a